Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1178-1185

  Aukrust, Pål ^a   Aandahl, Einar Martin ^b   Skålhegg, Bjørn S ^b   Nordøy, Ingvild ^a   Hansson, Vidar ^b   Taskén, Kjetil ^b   Frøland, Stig S ^a   Müller, Fredrik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CLONAL ANERGY; COMMON VARIABLE IMMUNODEFICIENCY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ADULT; AGED; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELL-FREE SYSTEM; COMMON VARIABLE IMMUNODEFICIENCY; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNE SERA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; THIONUCLEOTIDES;

EID: 0033555469     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Muraguchi, A., K. Miyazaki, J. H. Kehrl, and A. S. Fauci. 1984. Inhibition of B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. J. Immunol. 133:1283.
2. Kammer, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9:222.
3. Skålhegg, B. S., B. F. Landmark, S. O. Døskeland, V. Hansson, T. Lea, and T. Jahnsen. 1992. Cyclic AMP-dependent protein kinase type I mediate the inhibitory effects of 3′.5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 256:15707.
4. Scott, J. D. 1991. Cyclic nucleotide-dependent protein kinases. Pharmacol. Ther. 50:123.
5. Francis, S. H., and J. D. Corbin. 1994. Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol. 56:237.
6. Skålhegg, B. S., K. Tasken, V. Hansson, H. S. Huitfeldt, T. Jahnsen, and T. Lea. 1994. Location of cAMP-dependent protein kinase type I with the TCR/CD3 complex. Science 263:84.
7. Ledbetter, J. A., M. Parson, P. J. Martin, J. A. Hansen, P. S. Rabinovitch, and C. H. June. 1986. Antibody binding to CDS (Tp67) and Tp44 T cell surface molecules: effect on cyclic nucleotides, cytoplasmatic free calcium, and cAMP-mediated suppression. J. Immunol. 137:3299.
8. Kammer, G. M., C. A. Boehm, S. A. Rudolph, and L. A. Schultz. 1988. Mobility of the human T lymphocyte surface molecules CD3, CD4, and CD8: regulation by cAMP-dependent pathway. Proc. Natl. Acad. Sci. USA 85:792.
9. Kammer, G. M., I. U. Khan, and C. J. Malemud. 1994. Deficient type I protein kinase A isoenzyme activity in systemic lupus erythematosus. J. Clin. Invest. 94:422.
10. Spickett, G. P., S. A. Misbah, and H. M. Chapel. 1991. Primary antibody deficiency in adults. Lancet 337:281.
11. World Health Organization Scientific Group Report. 1995. Primary immunodeficiency diseases. Clin. Exp. Immunol. 97(Suppl. 1):1.
12. Spickett, G. P., A. D. B. Webster, and J. Farrant. 1990. Cellular abnormalities in common variable immunodeficiency. Immunodefic. Rev. 2:199.
13. Jaffe, J. S., E. Eisenstein, M. C. Sneller, and W. Strober. 1993. T-cell abnormalities in common variable immunodeficiency. Pediatr. Res. 33(Suppl.):S24.
14. Mayer, L. S., S. M. Fu, C. Cunningham-Rundles, and H. G. Kunkel. 1984. Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factor. J. Clin. Invest. 74:2115.
15. Nonoyama, S., M. Farrington, H. Ishida, M. Howard, and H. D. Ochs. 1993. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J. Clin. Invest. 92:1282.
16. Fiedler, W., K. W. Sykora, K. Welte, J. E. Kolitz, C. Cunningham-Rundles, K. Holloway, G. A. Miller, L. Souza, and R. Mertelsmann. 1987. T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogenic macrophages. Clin. Immunol. Immunopathol. 44:206.
17. Fischer, M. B., I. Hauber, H. Eggenbauer, V. Thon, E. Vogel, E. Schaffer, J. Lokaj, J. Litzman, H. M. Wolf, J. W. Mannhalter, and M. M. Eibl. 1994. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 84:4234.
18. Fischer, M. B., H. M. Wolf, I. Hauber, H. Eggenbauer, V. Thon, M. Sasgary, and M. M. Eibl. 1996. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur. J. Immunol. 26:231.
19. Laxminarayana, D., A. Berrada, and G. M. Krammer. 1993. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest. 92:2207.
20. Skålhegg, B. S., A. M. Rasmussen, K. Taskén, V. Hansson, T. Jahnsen, and T. Lea. 1994. Cyclic AMP sensitive signaling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex. Scand. J. Immunol. 40:201.
21. + lymphocytes. Clin. Immunol. Immunopathol. 770:217.
22. Aukrust, P., S. S. Frøland, and F. Müller. 1992. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunelogical parameters and to clinical and histological features. Clin. Exp. Immunol. 89:211.
23. Müller, F., H. Rollag, G. Gaudernack, and S. S. Frøland. 1990. Impaired in vitro survival of monocytes from patients with HIV infection. Clin. Exp. Immunol. 81:25.
24. Esin, S., G. Batoni, H. Källenius, H. Gaines, M. Campa, S. B. Svenson, R. Andersson, and H. Wigzell. 1996. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis or Mycobacterium avium. Clin. Exp. Immunol. 104:419.
25. Tasken, K., K. B. Andersson, B. S. Skålhegg, K. A. Tasken, V. Hansson, T. Jahnsen, and H. K. Blomhoff. 1993. Reciprocal regulation of mRNA and protein for subunits of cAMP-dependent protein kinase (RIα and Cα) by cAMP in a neoplastic B cell line (Reh). J. Biol. Chem. 268:23483.
26. Gjertsen, B. T., G. Mellgren, A. Otten, E. Maronde, H. G. Genieser, B. Jastorf, O. K. Vintermyr, G. S. McKnight, and S. O. Døskeland. 1995. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. J. Biol. Chem. 270:20599.
27. + lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor α system: possible immunopathogenic role of oxidative stress. Blood 86:1383.
28. Waldman, T. A. 1991. The interleukin-2 receptor. J. Biol. Chem. 266:2681.
29. + T cell differentiation. J. Clin. Immunol. 13:247.
30. Cunningham-Rundles, C., K. Kazbay, J. Hassett, Z. Zhou, and L. Mayer. 1994. Enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2. N. Engl. J. Med. 331:918.
31. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gere expression at multiple levels. J. Immunol. 148:2845.
32. Fischer, M. B., H. M. Wolf, H. Eggenbauer, V. Thon, E. Vogel, J. Lokaj, J. Litzmaru, J. W. Mannhalter, and M. M. Eibl. 1994. The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency. Clin. Exp. Immunol. 95:209.
33. North, M. E., A. N. Akbar, N. Borthwick, K. Sagawa, M. Funauchi, A. D. B. Webster, and J. Farrant. 1994. Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency. Clin. Exp. Immunol. 95:204.
34. 2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J. Exp. Med. 178:1813.
35. Spickett, G. P., J. Farrant, M. North, J.-G. Zhang, L. Morgan, and A. D. B. Webster. 1997. Common variable immunodeficiency: how many diseases? Immunol. Today 18:325.
36. + T cells define a unique subset of patients with common variable immunodeficiency. Blood 82:192.
37. Rump, J. A., A. Jahreis, M. Schlesier, S. Stecher, and P. H. Peter. 1997. A double blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 110:167.
38. Andersson, U., L. Björk, U. Skansén-Sapir, and J. Andersson. 1994. Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol. Rev. 139:325.
39. Achiron, A., R. Margalit, R. Herschkoviz, D. Markovits, T. Reshef, T. E. Melamed, J. R. Cohen, and O. Lider. 1994. Intravenous immunoglobulin treatment of experimental T-cell mediated autoimmune disease. J. Clin. Invest. 193:600.
40. Aukrust, P., E. Lien, A. K. Kristoffersen, F. Müller, C. J. Haug, T. Espevik, and S. S. Frøland. 1996. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency: possible immunological and clinical consequences. Blood 87:674.
41. Mulligham, C. G., G. C. Fanning, H. M. Chapel, and K. I. Welsh. 1997. TNF and lymphotoxin-α polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J. Immunol. 159:6236.
42. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptide: cAMP and cytokine patterns. Immunol. Today 16:595.
43. Spickett, G. P., M. Millrain, R. Beattie, M. North, J. Griffiths, S. Patterson, and A. D. B. Webster. 1988. Role of retroviruses in acquired hypogammaglobulinaemia. Clin. Exp. Immunol. 74:177.
44. Aandahl, E. M., P. Aukrust, B. S. Skålhegg, F. Müller, S. S. Frøland, V. Hansson, and K. Taskén. 1998. Protein kinase type I antagonist restores immune responses of T-cells from HIV-infected patients. FASEB J. 12:855.